Is early surgical referral for children with persistent otitis media with effusion (OME) appropriate?MORRIS, Peter S; LEACH, Amanda J.Medical journal of Australia. 2003, Vol 179, Num 8, pp 436-437, issn 0025-729X, 2 p.Article

Season of birth is not associated with delayed childhood mortality in Upper River Division, The GambiaJAFFAR, Shabbar; LEACH, Amanda; GREENWOOD, Alice et al.TM & IH. Tropical medicine & international health. 2000, Vol 5, Num 9, pp 628-632, issn 1360-2276Article

Development of the RTS,S/AS malaria candidate vaccineVEKEMANS, Johan; LEACH, Amanda; COHEN, Joe et al.Vaccine. Supplement. 2009, Vol 27, Num 6, issn 1359-5938, G67-G71Conference Paper

Viability of respiratory pathogens cultured from nasopharyngeal swabs stored for up to 12 years at — 70 °C in skim milk tryptone glucose glycerol brothHARE, Kim M; SMITH-VAUGHAN, Heidi C; LEACH, Amanda J et al.Journal of microbiological methods. 2011, Vol 86, Num 3, pp 364-367, issn 0167-7012, 4 p.Article

Haemophilus influenzae type b carriage in Indigenous children and children attending childcare centers in the Northern Territory, Australia, spanning pre- and post-vaccine erasJACUPS, Susan P; MORRIS, Peter S; LEACH, Amanda J et al.Vaccine. 2011, Vol 29, Num 16, pp 3083-3088, issn 0264-410X, 6 p.Article

Theories of otitis media pathogenesis, with a focus on Indigenous childrenWIERTSEMA, Selma P; LEACH, Amanda J.Medical journal of Australia. 2009, Vol 191, Num 9, issn 0025-729X, S50-S54, SUPArticle

Topical Ciprofloxin Versus Topical Framycetin-Gramicidin-Dexamethasone in Australian Aboriginal Children With Recently Treated Chronic Suppurative Otitis Media : A Randomized Controlled TrialLEACH, Amanda; WOOD, Yvonne; GADIL, Edna et al.The Pediatric infectious disease journal. 2008, Vol 27, Num 8, pp 692-698, issn 0891-3668, 7 p.Article

The burden and outcome of respiratory tract infection in Australian and aboriginal childrenLEACH, Amanda J; MORRIS, Peter S.The Pediatric infectious disease journal. 2007, Vol 26, Num 10, issn 0891-3668, S4-S7, SUPArticle

Long-Term Safety and Efficacy of the RTS,S/AS02A Malaria Vaccine in Mozambican ChildrenSACARLAL, Jahit; AIDE, Pedro; VEKEMANS, Johan et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 329-336, issn 0022-1899, 8 p.Article

Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western KenyaSTOUTE, José A; GOMBE, Joash; STEWART, V. Ann et al.Vaccine. 2007, Vol 25, Num 1, pp 176-184, issn 0264-410X, 9 p.Article

A clinical trial of prime-boost immunisation with the candidate malaria vaccines RTS,S/AS02A and MVA-CSDUNACHIE, Susanna J; WALTHER, Michael; WATKINS, Katherine et al.Vaccine. 2006, Vol 24, Num 15, pp 2850-2859, issn 0264-410X, 10 p.Article

Safety and immunogenicty of RTS,S/AS02A candidate malaria vaccine in Gambian childrenBOJANG, Kalifa A; OLODUDE, Folasade; RABINOVICH, Regina et al.Vaccine. 2005, Vol 23, Num 32, pp 4148-4157, issn 0264-410X, 10 p.Article

Immunogenicity and safety of the candidate RTS,S/AS01 vaccine in young Nigerian children: A randomized, double-blind, lot-to-lot consistency trialUMEH, Rich; OGUCHE, Stephen; CATTEAU, Gregory et al.Vaccine. 2014, Vol 32, Num 48, pp 6556-6562, issn 0264-410X, 7 p.Article

Four-Year Efficacy of RTS,S/AS01E and Its Interaction with Malaria ExposureOLOTU, Ally; FEGAN, Gregory; MARSH, Kevin et al.The New England journal of medicine. 2013, Vol 368, Num 12, pp 1111-1120, issn 0028-4793, 10 p.Article

Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. CommentaryALONSO, Pedro L; SACARLAL, Jahit; BASSAT, Quique et al.Lancet (British edition). 2004, Vol 364, Num 9443, pp 1380-1383, issn 0140-6736, 14 p.Article

Evaluation of the Safety and Immunogenicity of the RTS,S/AS01_E Malaria Candidate Vaccine When Integrated in the Expanded Program of ImmunizationAGNANDJI, Selidji T; ASANTE, Kwaku Poku; CHIKAWE, Maria et al.The Journal of infectious diseases. 2010, Vol 202, Num 7, pp 1076-1087, issn 0022-1899, 12 p.Article

Efficacy of RTS,S/AS01E Vaccine against Malaria in Children 5 to 17 Months of AgeBEJON, Philip; LUSINGU, John; DEMOITIE, Marie-Ange et al.The New England journal of medicine. 2008, Vol 359, Num 24, pp 2521-2532, issn 0028-4793, 12 p.Article

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique : a double blind randomised controlled phase I/IIb trial. CommentaryEPSTEIN, Judith E; APONTE, John J; LEACH, Amanda et al.Lancet (British edition). 2007, Vol 370, Num 9598, issn 0140-6736, 1523-1524, 1543-1551 [11 p.]Article

Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria : progress at the Walter Reed army institute of researchGRAY HEPPNER, D; KESTER, Kent E; MORIS, Philippe et al.Vaccine. 2005, Vol 23, Num 17-18, pp 2243-2250, issn 0264-410X, 8 p.Conference Paper

Effects of misclassification of causes of death on the power of a trial to assess the efficacy of a pneumococcal conjugate vaccine in The GambiaJAFFAR, Shabbar; LEACH, Amanda; SMITH, Peter G et al.International journal of epidemiology. 2003, Vol 32, Num 3, pp 430-436, issn 0300-5771, 7 p.Article

Effect of the Pre-erythrocytic Candidate Malaria Vaccine RTS,S/AS01_E on Blood Stage Immunity in Young ChildrenBEJON, Philip; COOK, Jackie; DUTTA, Sheetij et al.The Journal of infectious diseases. 2011, Vol 204, Num 1, pp 9-18, issn 0022-1899, 10 p.Article

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5-17 months in Kenya and Tanzania: a randomised controlled trialOLOTU, Ally; LUSINGU, John; VANSADIA, Preeti et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 2, pp 102-109, issn 1473-3099, 8 p.Article

Four year immunogenicity of the RTS,S/AS02_A malaria vaccine in Mozambican children during a phase IIb trialAIDE, Pedro; DOBANO, Carlota; HERREROS, Esperanza et al.Vaccine. 2011, Vol 29, Num 35, pp 6059-6067, issn 0264-410X, 9 p.Article

Safety and efficacy of the RTS,S/AS01_E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trialKWAKU POKU ASANTE; ABDULLA, Salim; SALIM, Nahya et al.Lancet. Infectious diseases (print). 2011, Vol 11, Num 10, pp 741-749, issn 1473-3099, 9 p.Article

Safety of the RTS,S/AS02A malaria vaccine in Mozambican children during a Phase IIb trialSACARLAL, Jahit; APONTE, John J; OFORI-ANYINAM, Opokua et al.Vaccine. 2008, Vol 26, Num 2, pp 174-184, issn 0264-410X, 11 p.Article